Young soccer players in most organized leagues are classified per team based on their chronological age, usually with a threshold set at January 1. For example, if a player was 16 years old on January 1, 2018, he or she is considered part of the under 16 (U16) age group for the 2018-2019 season. Peak height velocity (PHV) defines the moment of the largest increase in body height.^[@bibr12-2325967118811042],[@bibr15-2325967118811042]^ As the velocity of growth differs between players, biological differences are likely to occur within teams. The differences in height and weight can imply differences in physical capacity.

Periods around PHV have been associated with an increased injury risk.^[@bibr13-2325967118811042],[@bibr23-2325967118811042],[@bibr24-2325967118811042]^ A decrease in flexibility and bone density during the growth spurt may result in increased vulnerability of the skeletal system.^[@bibr2-2325967118811042][@bibr3-2325967118811042]--[@bibr4-2325967118811042],[@bibr10-2325967118811042],[@bibr22-2325967118811042]^ Boys between 12 and 16 years of age can grow up to 12 cm per year.^[@bibr15-2325967118811042]^ Adolescent "clumsiness" due to the quick increase in the length of arms and legs relative to the trunk may result in physical impairments and lower performance during this period.^[@bibr3-2325967118811042]^ Furthermore, increased training loads and match congestion in youth soccer academies are associated with an increased injury incidence in this group of athletes.^[@bibr9-2325967118811042]^ A recent review suggested that both an increased load and height gain augmented the risk of sustaining an injury.^[@bibr16-2325967118811042]^

The injury incidence density (IID) in academy soccer players (2.0-19.4 injuries per 1000 hours of soccer participation) is higher than that in male professional players (2.5-9.4).^[@bibr16-2325967118811042]^ In both groups, the IID in training (1.4-5.8 and 3.7-11.1, respectively) is lower than in matches (8.7-65.9 and 9.5-48.7, respectively).^[@bibr16-2325967118811042]^ Recent studies in English soccer academies (age groups of U11-U18) and Qatari youth players (U9-U18) have reported 1.3 and 1.5 injuries per player per season, respectively.^[@bibr13-2325967118811042]^ Time loss per injury was significantly higher in the U14 and U15 groups when compared with the U11 to U13 groups and the U16 group,^[@bibr13-2325967118811042]^ whereas the number of injuries was significantly higher in the U15 group (2.7 per player per season) compared with the U13 (1.3 per player per season) and U14 groups (1.7 per player per season).^[@bibr13-2325967118811042]^ Older academy players (U17-U19) were at a higher risk to sustain a severe injury when compared with younger players (U9-U16).^[@bibr20-2325967118811042]^ However, these studies^[@bibr13-2325967118811042],[@bibr16-2325967118811042],[@bibr20-2325967118811042]^ did not report on exposure and thus lack an estimate of the injury risk.

In Dutch academy soccer players, a higher IID of acute injuries was found in the period from 6 months before PHV to 6 months after PHV when compared with the year before this period.^[@bibr23-2325967118811042]^ Another study found more overuse injuries present in the period from 1 year before PHV to 1 year after PHV and more time loss due to acute injuries from 1 year after PHV.^[@bibr23-2325967118811042]^

The little information available, derived from different cohorts, age groups, and study designs, as well as the contrary outcomes, warrants new studies on this topic.^[@bibr13-2325967118811042],[@bibr23-2325967118811042],[@bibr24-2325967118811042]^ Our aim in the current study was to investigate the associations between the injury risk and injury burden with both height increase (periods around PHV) and chronological age groupings (U12-U19) in talented youth male soccer players.

Methods {#section1-2325967118811042}
=======

In this study, we observed 170 academy soccer players of a professional Dutch Premier League club who played in the U12 to U19 groups during the seasons 2013-2014 and/or 2014-2015 and/or 2015-2016. Players were included when they (1) played in the academy for at least 1 full season to a maximum of 3 seasons, (2) had at least 1 PHV measurement taken, (3) had complete injury registration over the season(s) during the study, and (4) had training and match exposure registration over the season(s) during the study.

As data for this study were routinely collected in the academy program, players were not exposed to an extra burden of measurements or activities. At the start of the study, the Dutch Central Committee on Research Involving Human Subjects (CCMO) confirmed that no ethical approval was needed, as stated in the Dutch Medical Research Involving Human Subjects Act (WMO). Parents gave their written informed consent to use the anonymized data for scientific purposes. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement was used to report the findings of this study.^[@bibr26-2325967118811042]^

Measurements and Procedures {#section2-2325967118811042}
---------------------------

Body weight was measured with a weight scale (Seca 700; Seca) with 50-g increments. This scale was calibrated every 3 months. Body height was assessed with a verified measuring rod (Seca 220; Seca). Players stood upright with their head positioned in the Frankfort horizontal plane. They were barefoot while wearing underwear and soccer shorts, with their feet positioned together.^[@bibr15-2325967118811042]^ Standing and sitting height were registered in 0.5-cm increments. For sitting height, the maximum distance from the top to the buttocks was measured while the player was sitting on a standard 50-cm box with his hands on the upper legs, looking straightforward and holding his breath after deeply inhaling. All measurements were taken in the afternoon between 3:00 PM and 5:00 PM before a training session. An experienced (\>4 years) assessor performed all PHV measurements.

Peak Height Velocity {#section3-2325967118811042}
--------------------

The age at PHV was calculated according to the algorithm of Mirwald et al^[@bibr15-2325967118811042]^ (*R* ^2^ = 0.92, standard error of the estimate = 0.49):
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where *A* is the standing height (cm), *B* is the sitting height (cm), *C* is the chronological age (years), and *D* is the weight (kg).

When more than 1 PHV measurement was obtained, the measurement of the date closest to the estimated age of PHV was used to attain the most reliable estimate of PHV.^[@bibr15-2325967118811042]^

PHV Periods {#section4-2325967118811042}
-----------

To allow the comparison of IID in different PHV periods with previous findings^[@bibr13-2325967118811042],[@bibr23-2325967118811042],[@bibr24-2325967118811042]^ and clinical observations from the Athletic Skills Model (ASM),^[@bibr27-2325967118811042]^ we identified 6 periods. The pre-PHV periods were PHV 1 (\>12 months before PHV), PHV 2 (6-12 months before PHV), and PHV 3 (\<6 months before PHV). The post-PHV periods were PHV 4 (\<3 months after PHV), PHV 5 (3-6 months after PHV), and PHV 6 (\>6 months after PHV). The combination of PHV periods 4 and 5 was used to compare equally long periods of 6 months before (PHV 2 and 3) and after (PHV 4+5) PHV. We compared periods both individually and in combinations according to van der Sluis et al^[@bibr23-2325967118811042],[@bibr24-2325967118811042]^ and the ASM^[@bibr27-2325967118811042]^ ([Table 1](#table1-2325967118811042){ref-type="table"}).

###### 

Classification of PHV Periods in Other Studies/Models and Those in the Current Study*^a^*

![](10.1177_2325967118811042-table1)

  ---------------------------------------------------------------------------- --------- ---------- -------- --------- --------- ---------
                                                                               Pre-PHV   Post-PHV                                
  \>12 mo                                                                      6-12 mo   \<6 mo     \<3 mo   3-6 mo    7-12 mo   \>12 mo
  Materne et al^[@bibr13-2325967118811042]^                                    1         2          3                            
  van der Sluis et al^[@bibr23-2325967118811042],[@bibr24-2325967118811042]^   1         2          3                            
  ASM^[@bibr27-2325967118811042]^                                              1         2          3                            
  Current study                                                                PHV 1     PHV 2      PHV 3    PHV 4+5   PHV 6     
  ---------------------------------------------------------------------------- --------- ---------- -------- --------- --------- ---------

*^a^*1, time before PHV period; 2, defined period around PHV; 3, time after PHV period; ASM, Athletic Skills Model; PHV, peak height velocity.

Age Groups {#section5-2325967118811042}
----------

Team formation at the soccer academy is based on chronological age, per year, ranging from U12 to U19. Players aged 17 and 18 years play in the U19 group (there is no separate U18 group).

Injury Registration {#section6-2325967118811042}
-------------------

All players had to contact the club's medical staff in case of an injury. According to the consensus statement on injury reporting in soccer,^[@bibr7-2325967118811042]^ an injury was defined as any physical complaint resulting from a soccer match or training that prevented a player from taking full part in future soccer training or match play. The sports medicine physician and/or sports physical therapist performed all diagnoses and registered them according to the Orchard Sports Injury Classification System.^[@bibr19-2325967118811042]^ The location (body region), type (medical or tissue diagnosis), and character (acute/overuse) of the injury were coded according to a standard list. The dates of injury and return to sport (defined as the moment of full re-participation in training and/or match play) were recorded.

Injury severity was defined as the number of days that a player was unable to participate fully in training or match play as a result of the injury. This was categorized as minimal (1-3 days), mild (4-7 days), moderate (8-28 days), or severe (\>28 days).^[@bibr19-2325967118811042]^ Whether injuries were growth specific (ie, apophysitis) could not be retrieved from the data.

Exposure {#section7-2325967118811042}
--------

Exposure was registered in minutes by the trainer/coach. Match exposure was registered at an individual level. Training exposure was registered at a team level. Missed training exposure as a result of injury was recorded. Individual exposure was calculated as ((*match exposure* + *training exposure*) -- *missed training exposure*) for every player per age group and every individual PHV period.

Statistical Analysis {#section8-2325967118811042}
--------------------

All descriptive variables (age at PHV, chronological age, and duration of injury) were assessed for normality (Shapiro-Wilk test). Normally distributed data are reported as mean ± SD and range when applicable. Nonnormally distributed data are reported as median with interquartile range (IQR). Descriptive data on sustained injuries (total, acute, and overuse) and their body location and severity (duration and days of time loss) are presented as counts and percentages. Statistical analyses were performed with SPSS 22.0 (IBM).

The primary outcome measure was IID,^[@bibr25-2325967118811042]^ which was calculated per subgroup (for all separate and combined PHV periods and age groups as ((*number of injuries*/*hours of exposure*) × 1000). To compare the injury risk between groups, the incidence ratio (IR) was calculated as the chance of sustaining an injury and compared with the chance found in the total group according to the following formula: (*IID subgroup*)/(*IID total group*). For IID and IR, 95% CIs were calculated. When the 95% CI of an IR did not pass the "1" value, the IIDs were considered different between groups. For example, an IR of 1.25 indicates that the chance of sustaining an injury in that specific subgroup is 25% higher than in the total group. In case of an IR of 0.70, this chance is 30% lower.^[@bibr25-2325967118811042]^ *P* values were calculated using *Z* scores (lowest 95% CI value of IR/highest 95% CI value of IR). The alpha level for statistical significance was set at .05.

The secondary outcome measure was injury burden. Because of the skewed distribution, we used the median to calculate the injury burden (*number of injuries* × *median number of time-loss days per injury*) per 1000 hours of soccer exposure.^[@bibr1-2325967118811042]^ To compare the injury burden of subgroups with the overall injury burden, the burden ratio (BR) and 95% CI were calculated similar to the IR for the IID. Again, *Z* scores were used to calculate *P* values.

Results {#section9-2325967118811042}
=======

The original cohort consisted of 175 soccer players. Of these, 5 players were excluded because they had no PHV measurement taken as a result of illness or an in-season transfer to another club. Of the remaining 170 players, 35 were observed over 3 seasons, 64 over 2 seasons, and 71 over 1 season. The U13 to U16 groups were observed over 3 seasons, U17 and U19 groups over 2 seasons, and U12 group over 1 season ([Figure 1](#fig1-2325967118811042){ref-type="fig"}).

![(A) Flowchart of inclusion and exclusion and numbers of observed players over consecutive seasons. (B) Numbers of observed players per season and per team. PHV, peak height velocity.](10.1177_2325967118811042-fig1){#fig1-2325967118811042}

The mean age at PHV was 14.4 ± 0.65 years (range, 12.8-16.5 years). The biological age of players within a single team could be 3 years apart (highest/lowest), with the largest variance found in the U15 group (3.1 years). Of all 170 players, 148 (87.1%) together sustained a total of 620 injuries (range, 1-19 injuries per player), of which 468 (75.5%) were acute and 152 (24.5%) were overuse injuries ([Table 2](#table2-2325967118811042){ref-type="table"}). The total group sustained a mean of 2.0 injuries per player per season. Most injuries (n = 528, 85.2%) concerned the lower extremity, of which 393 (74.4%) were acute and 135 (25.6%) were overuse injuries. The most prevalent locations for acute injuries were the ankle (n = 114, 24.3%), thigh (n = 95, 20.2%), knee (n = 64, 13.6%), and hip/groin (n = 45, 10.4%). For overuse injuries, the hip/groin (n = 57, 37.5%) and knee (n = 39, 25.7%) were the most common locations. Among the 468 acute injuries were 207 strains, 170 sprains, and 27 fractures.

###### 

Injuries by Location, Type, and Severity

![](10.1177_2325967118811042-table2)

                                               Injury Type, n (%)   Severity,*^a^* n                     
  ------------------------------ ------------- -------------------- ------------------ ----- ----- ----- ----
  Head/spine/belly/pelvis                                                                                
   Head/face                     11 (1.8)      11 (2.4)             0 (0.0)            3     2     5     1
   Neck/cervical spine           2 (0.3)       2 (0.4)              0 (0.0)            1     0     1     0
   Sternum/ribs/thoracic spine   4 (0.6)       3 (0.6)              1 (0.1)            2     0     2     0
   Belly                         2 (0.3)       1 (0.2)              1 (0.1)            0     1     1     0
   Lumbar spine/pelvic           40 (6.5)      25 (5.3)             15 (9.9)           13    11    10    6
   Subtotal                      59 (9.5)      42 (8.9)             17 (11.2)          19    14    19    7
  Upper extremity                                                                                        
   Shoulder/clavicle             8 (1.3)       8 (1.5)              0 (0.0)            5     1     1     1
   Upper arm                     1 (0.2)       1 (0.2)              0 (0.0)            1     0     0     0
   Elbow                         4 (0.6)       4 (0.9)              0 (0.0)            0     2     1     1
   Forearm                       4 (0.6)       4 (0.9)              0 (0.0)            0     1     2     1
   Wrist                         11 (1.8)      11 (2.4)             0 (0.0)            3     1     6     1
   Hand/finger/thumb             5 (0.8)       5 (1.1)              0 (0.0)            4     0     1     0
   Subtotal                      33 (5.3)      33 (7.0)             0 (0.0)            13    5     11    4
  Lower extremity                                                                                        
   Hip/groin                     102 (16.5)    45 (10.4)            57 (37.5)          31    23    35    13
   Thigh                         106 (17.1)    95 (20.2)            11 (7.2)           31    23    36    16
   Knee                          103 (16.6)    64 (13.6)            39 (25.7)          29    15    36    23
   Lower leg/Achilles tendon     55 (8.9)      44 (9.4)             11 (7.2)           21    9     24    1
   Ankle                         121 (19.5)    114 (24.3)           7 (4.6)            47    20    32    22
   Foot/toe                      41 (6.6)      31 (6.6)             10 (6.6)           10    7     15    9
   Subtotal                      528 (85.2)    393 (84.5)           135 (88.8)         169   97    178   84
  Total                          620 (100.0)   468 (100.0)          152 (100.0)        201   116   208   95

*^a^*Defined as the number of days that a player was unable to participate fully in training or match play as a result of the injury.

The most prevalent injuries were bruises (n = 174, 28.1%), muscle injuries (n = 173, 27.9%), tendon injuries (n = 81, 13.1%), ligament injuries (n = 78, 12.6%), and fractures/other bone injuries (n = 56, 9.1%). The injury duration was not normally distributed. The mean duration was 16.8 ± 30.8 days, and the median was 7.0 days (IQR, 15; range, 1-371 days).

Injury Incidence Density {#section10-2325967118811042}
------------------------

The overall mean IID was 8.34 injuries per 1000 hours of soccer exposure (95% CI, 7.71-9.02). For acute injuries, the IID was 6.29 (95% CI, 5.75-6.89) and for overuse injuries it was 2.04 (95% CI, 1.74-2.40). Compared with the overall IID, the IID in PHV period 4+5 (6 months after PHV) was significantly higher (IR, 1.31 \[95% CI, 1.00-1.71\]; *P* = .049) ([Table 3](#table3-2325967118811042){ref-type="table"} and [Figure 2A](#fig2-2325967118811042){ref-type="fig"}), and the IID in PHV period 1 was significantly lower (IR, 0.77 \[95% CI, 0.62-0.95\]; *P* = .016). The IID for PHV periods 2, 3, and 6 were not significantly different when compared with the overall mean ([Table 3](#table3-2325967118811042){ref-type="table"}).

###### 

IID, IR, Injury Burden, and BR by PHV Period According to the Classification of the Current Study, van der Sluis et al,^[@bibr23-2325967118811042],[@bibr24-2325967118811042]^ and the ASM^[@bibr27-2325967118811042]^ *^a^*

![](10.1177_2325967118811042-table3)

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Classification per Current Study                                                                                                                                                                                                
  ----------------------------------------------------------------------------------------------- --------------------- --------------------- --------------------------------------- --------------------- --------------------- ---------------------
  IID (95% CI)                                                                                    8.34 (7.71-9.02)      6.38 (5.22-7.81)      8.69 (6.51-11.60)                       8.28 (6.22-11.02)     10.92 (8.44-14.13)    8.66 (7.82-9.58)

  IR (95% CI)                                                                                     1.00                  0.77 (0.62-0.95)      1.04 (0.77-1.41)                        0.99 (0.74-1.34)      1.31 (1.00-1.71)      1.04 (0.91-1.18)

   *P* value                                                                                                            .016*^b^*             .786                                    .965                  .049*^b^*             .566

  Injury burden (95% CI)                                                                          58.37 (56.66-60.13)   44.69 (41.42-48.22)   43.46 (38.19-49.46)                     57.98 (52.04-64.60)   89.45 (81.76-97.87)   60.60 (58.32-62.97)

  BR (95% CI)                                                                                     1.00                  0.77 (0.71-0.83)      0.74 (0.65-0.85)                        0.99 (0.89-1.11)      1.53 (1.39-1.68)      1.04 (0.99-1.09)

   *P* value                                                                                                            \<.001*^b^*           \<.001*^b^*                             .907                  \<.001*^b^*           .129

  Classification per van der Sluis et al^[@bibr23-2325967118811042],[@bibr24-2325967118811042]^                                                                                                                                   

                                                                                                  \                     PHV 1-2\              PHV 3-5 (6 mo before--6 mo after PHV)   PHV 6\                                      
                                                                                                  Total                 (\>6 mo to PHV)                                               (\>6 mo after PHV)                          

  IID (95% CI)                                                                                    8.34 (7.71-9.02)      6.99 (5.93-8.24)      9.56 (7.89-11.57)                       8.66 (7.82-9.58)                            

  IR (95% CI)                                                                                     1.00                  0.84 (0.70-1.01)      1.15 (0.93-1.41)                        1.04 (0.91-1.18)                            

   *P* value                                                                                                            .059                  .195                                    .566                                        

  Injury burden (95% CI)                                                                          58.37 (56.66-60.13)   44.37 (41.55-47.37)   73.19 (68.30-78.43)                     60.60 (58.32-62.97)                         

  BR (95% CI)                                                                                     1.00                  0.76 (0.70-0.82)      1.25 (1.16-1.36)                        1.04 (0.98-1.10)                            

   *P* value                                                                                                            \<.001*^b^*           \<.001*^b^*                             .174                                        

  Classification per the ASM                                                                                                                                                                                                      

                                                                                                  \                     PHV 1\                PHV 2-4\                                PHV 5-6\                                    
                                                                                                  Total                 (\>12 mo to PHV)      (12 mo before--3 mo after PHV)          (\>3 mo after PHV)                          

  IID (95% CI)                                                                                    8.34 (7.71-9.02)      6.38 (5.22-7.81)      9.09 (7.62-10.85)                       8.75 (7.93-9.65)                            

  IR (95% CI)                                                                                     1.00                  0.77 (0.62-0.95)      1.09 (0.90-1.32)                        1.05 (0.93-1.19)                            

   *P* value                                                                                                            .015                  .382                                    .451                                        

  Injury burden (95% CI)                                                                          58.37 (56.66-60.13)   44.69 (41.42-48.22)   55.71 (51.88-59.84)                     63.08 (60.82-65.42)                         

  BR (95% CI)                                                                                     1.00                  0.77 (0.70-0.83)      0.95 (0.88-1.04)                        1.08 (1.03-1.14)                            

   *P* value                                                                                                            \<.001*^b^*           .260                                    .004*^b^*                                   
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*^a^*ASM, Athletic Skills Model; BR, burden ratio; IID, injury incidence density; IR, incidence ratio; PHV, peak height velocity.

*^b^*Statistically significant difference (*P* \< .05) compared with the value for the total cohort in the current study for injury risk (top set) and injury burden (bottom set).

![(A) Injury incidence density (IID) and (B) injury burden for different peak height velocity (PHV) periods compared with the mean of the total cohort. (B) Injury burden (number of injuries × median injury days per 1000 hours of exposure). The boxes and whiskers depict the IID and injury burden and their 95% CI per PHV group. The horizontal dotted line and gray bar depict the mean IID and injury burden and their 95% CI. \*Statistically significant difference (*P* \< .05) compared with the value for the total cohort.](10.1177_2325967118811042-fig2){#fig2-2325967118811042}

A comparison of PHV periods according to van der Sluis et al^[@bibr23-2325967118811042],[@bibr24-2325967118811042]^ showed no significant differences in the injury risk for their PHV periods compared with the overall mean. According to the ASM classification, the IID in PHV period 1 was significantly lower than that in the total group (IR, 0.77 \[95% CI, 0.62-0.95\]; *P* \< .016) ([Figure 2A](#fig2-2325967118811042){ref-type="fig"}).

The IID in the U15 group was higher (IR, 1.49 \[95% CI, 1.24-1.79\]; *P* \< .001) than that for the total group ([Table 4](#table4-2325967118811042){ref-type="table"} and [Figure 3A](#fig3-2325967118811042){ref-type="fig"}). In the U17 group, we observed a trend toward a higher IID (IR, 1.21 \[95% CI, 1.00-1.48\]; *P* = .053). In the U13 group, a lower IID was found (IR, 0.61 \[95% CI, 0.46-0.82\]; *P* \< .001) when compared with the total group ([Table 4](#table4-2325967118811042){ref-type="table"} and [Figure 3A](#fig3-2325967118811042){ref-type="fig"}).

###### 

IID, IR, Injury Burden, and BR by Age Group*^a^*

![](10.1177_2325967118811042-table4)

                                       Total                 U12                   U13                   U14                   U15                   U16                   U17                   U19
  ------------------------------------ --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- ---------------------
  Injury duration, median (range), d   7.0 (1-371)           9.0 (1-59)            10.0 (1-110)          5.0 (1-371)           6.0 (1-143)           10.0 (1-295)          7.0 (1-277)           7.0 (1-158)
  Injuries per player per season       2.0                   1.2                   1.0                   1.6                   2.6                   2.1                   3.1                   2.2
  Exposure time, h                     74,358                3583                  9965                  11,332                11,175                13,066                11,761                13,475
  IID (95% CI)                         8.34 (7.71-9.02)      5.86 (3.82-8.99)      5.12 (3.89-6.73)      7.41 (5.99-9.18)      12.44 (10.53-14.69)   8.65 (7.19-10.40)     10.12 (8.45-12.11)    6.90 (5.63-8.46)
  IR (95% CI)                          1.00                  0.70 (0.45-1.09)      0.61 (0.46-0.82)      0.89 (0.71-1.12)      1.49 (1.24-1.79)      1.04 (0.85-1.27)      1.21 (1.00-1.48)      0.83 (0.67-1.03)
   *P* value                                                 .112                  \<.001*^b^*           .312                  \<.001*^b^*           .721                  .053                  .089
  Injury burden (95% CI)               58.37 (56.66-60.13)   52.74 (45.74-60.83)   51.18 (46.92-55.82)   37.06 (33.68-40.78)   74.63 (69.74-79.87)   86.48 (81.58-91.67)   70.82 (66.17-75.80)   48.31 (44.74-52.17)
  BR (95% CI)                          1.00                  0.90 (0.78-1.05)      0.88 (0.80-0.96)      0.63 (0.57-0.70)      1.28 (1.19-1.38)      1.48 (1.39-1.58)      1.21 (1.13-1.31)      0.83 (0.76-0.90)
   *P* value                                                 .173                  \<.001*^b^*           \<.001*^b^*           \<.001*^b^*           \<.001*^b^*           \<.001*^b^*           \<.001*^b^*

*^a^*BR, burden ratio; IID, injury incidence density; IR, incidence ratio; U12, under 12 (U13, under 13; etc).

*^b^*Statistically significant difference (*P* \< .05) compared with the value for the total cohort in the current study for injury risk (top set) and injury burden (bottom set).

![(A) Injury incidence density (IID) and (B) injury burden for different age groups compared with the mean of the total cohort. (B) Injury burden (number of injuries × median injury days per 1000 hours of exposure). The boxes and whiskers depict the IID and injury burden and their 95% CI per age group. The horizontal dotted line and gray bar depict the mean IID and injury burden and their 95% CI. U12, under 12 (U13, under 13; etc). \*Statistically significant difference (*P* \< .05) compared with the value for the total cohort.](10.1177_2325967118811042-fig3){#fig3-2325967118811042}

Injury Burden {#section11-2325967118811042}
-------------

The overall injury burden was 58.37 injury days per 1000 hours of soccer exposure (95% CI, 56.66-60.13). In PHV period 4+5, the injury burden was significantly higher (BR, 1.53 \[95% CI, 1.39-1.68\]; *P* \< .001) when compared with the overall mean ([Table 3](#table3-2325967118811042){ref-type="table"} and [Figure 2B](#fig2-2325967118811042){ref-type="fig"}). A comparison of age groups showed the highest injury burden in the U16 group (86.48 \[95% CI, 81.58-91.67\]), which was also significantly higher (BR, 1.48 \[95% CI, 1.39-1.58\]; *P* \< .001). The injury burden in the U15 and U17 groups was also significantly higher compared to overall. This is in contrast to the significantly lower injury burden in the U13, U14, and U19 groups ([Table 4](#table4-2325967118811042){ref-type="table"} and [Figure 3B](#fig3-2325967118811042){ref-type="fig"}).

A comparison of the injury risk in PHV periods with the overall mean according to van der Sluis et al^[@bibr23-2325967118811042],[@bibr24-2325967118811042]^ showed a higher injury burden in PHV period 3-5 (BR, 1.25 \[95% CI, 1.16-1.36\]; *P* \< .001). According to the ASM classification, the injury burden in PHV period 5-6 was significantly higher compared with overall (BR, 1.08 \[95% CI, 1.03-1.14\]; *P* = .004) ([Table 3](#table3-2325967118811042){ref-type="table"}).

Discussion {#section12-2325967118811042}
==========

Young, talented soccer players have a higher injury risk and injury burden during the first 6 months after their PHV when compared with the overall mean. Comparisons for age groups revealed that the injury risk in the U15 group was higher than the overall mean. Among age groups, the injury burden in the U16 group was highest, and the injury burden in the U15 and U17 groups was higher than the overall mean as well. These findings imply that for both age groups and PHV periods, differences exist regarding injury risk parameters. We discuss our findings below.

Injury Characteristics {#section13-2325967118811042}
----------------------

Most injuries (85.2%) were located in the lower extremity, with the highest prevalence in the ankle (19.5%), thigh (17.1%), knee (16.6%), and hip/groin (16.5%) regions. This is in line with the study of Price et al,^[@bibr18-2325967118811042]^ who reported percentages of 19%, 19%, 18%, and 13%, respectively. Strains and sprains were the most prevalent injury types in both our study and their study.^[@bibr16-2325967118811042]^ The mean injury duration of 16.8 days is also comparable with previous reports (12.5-26.3 days).^[@bibr5-2325967118811042],[@bibr11-2325967118811042]^ As we found that the injury duration data were nonnormally distributed (skewed to the right), we used the median (7.0 days) in our study.

Injury Risk and Injury Burden {#section14-2325967118811042}
-----------------------------

The IID is the most commonly used outcome measure to describe the injury risk. The duration of an injury reflects the consequences for such an injury for both the player and the team. The injury burden was recently proposed by Bahr et al^[@bibr1-2325967118811042]^ as an additional and relevant outcome measure. The question is whether 1 long-standing injury of 200 days has more impact than, for example, 10 separate injuries of 15 days. In the first situation, 1 player needs to be replaced, whereas 10 players need to be replaced in the second situation. Furthermore, because long-standing injuries occur less frequently, their impact on the injury burden and BR between groups will be high. We therefore propose the injury burden to be calculated as (*median injury duration \[in days\]* × *number of injuries divided by exposure time \[in days\]*) to avoid overestimation due to single injuries of long duration. In our study, compared with overall, both the IID and injury burden were higher in the first 6 months after PHV and in the U15 group. In the U16 and U17 groups, the IID was not significantly higher, but based on the higher injury burden, these groups should also be considered as having a higher injury risk.

Comparison With Previous Studies {#section15-2325967118811042}
--------------------------------

The higher injury risk found for the U15 group in our study is in line with results from previous studies.^[@bibr13-2325967118811042],[@bibr20-2325967118811042]^ However, a strict comparison is difficult, as these studies did not use exposure time in their risk comparisons. The higher injury risk that we found in the first 6 months after PHV is not in line with the higher risk period of 6 months before PHV to 6 months after PHV found by van der Sluis et al,^[@bibr24-2325967118811042]^ nor with the period from 1 year before PHV to 1 year after PHV found by Materne et al.^[@bibr13-2325967118811042]^ We followed an open cohort of 170 players (7 teams, U12-U19) up to a maximum of 3 seasons. Materne et al^[@bibr13-2325967118811042]^ also followed an open cohort (n = 289, 10 teams, U9-U18) of Qatari academy players over 1 season, and van der Sluis et al^[@bibr23-2325967118811042],[@bibr24-2325967118811042]^ followed a smaller closed cohort (N = 26) over 3 seasons. In a closed cohort, a possible bias could be that the players who completed the full 3 years had fewer injuries. The "survival of the fittest" phenomenon may result in bias of the less serious injuries. In our opinion, the open inflow and outflow of players during the follow-up in our study represent more adequately the true setting and situation of players in an academy over several years. Differences in study designs (open vs closed cohort, age, teams) and training methods between clubs and individual teams may have contributed to the differences observed between studies. Considering the mean age at PHV of 14.4 ± 0.65 years in our study, the high-risk period of the first 6 months after PHV seems to coincide with the higher risk of injury in the U15 group. Large longitudinal studies are needed to further investigate the interaction between age groups and PHV periods.^[@bibr22-2325967118811042]^

Exposure and Athletic Load {#section16-2325967118811042}
--------------------------

The increased vulnerability in the identified groups may relate to the athletic loading volume (hours of sport per week).^[@bibr6-2325967118811042],[@bibr14-2325967118811042],[@bibr17-2325967118811042]^ It is advocated that younger players not take part in sport regimens for more hours per week than their age is in years. We found that the players' soccer exposure in the academy was lower in all teams than their chronological age. All teams trained 4 times per week and played 1 or 2 matches lasting 60 (U12 and U13), 70 (U14 and U15), 80 (U16 and U17), or 90 (U19) minutes. We acknowledge that the soccer (or any other) load outside the academy (ie, at home or school) was not registered. The training load between age groups could have differed in our study, but this was not registered at the individual level. Therefore, acute and chronic workload ratios as potential influencers could not be calculated.^[@bibr8-2325967118811042]^ Furthermore, upon reaching PHV, players may experience reduced load tolerance. In this period, a comparable training volume due to a reduced load capacity could imply an increased training load for an individual player. Continuous registration of perceived training loads and the IID is needed to further investigate this assumption.

Practical and Scientific Applications {#section17-2325967118811042}
-------------------------------------

As obtaining PHV measurements is time (and thus budget) consuming, this may only be organized in academies of professional soccer clubs. However, the accuracy of the method of Mirwald et al^[@bibr15-2325967118811042]^ should be taken into consideration when these measurements are obtained. The observed higher injury risk (U15) and injury burden (U15, U16, and U17) in certain age groups (85.2% located in the lower extremity) suggest that future research into the underlying causes for the increased risk and duration of injuries in these groups is warranted. Study designs should ideally include large cohorts, comparable PHV periods, and registration methods of exposure time and workload to enable comparisons and/or data pooling between studies.

Limitations {#section18-2325967118811042}
-----------

This study has its limitations. A possible interaction effect between the PHV periods and chronological age groups was not investigated. The mix of a cross-sectional and longitudinal design combined with an underpowered data did not allow further analysis of interaction effects. We only had data from 1 season for the U12 group and data from 2 seasons for the U17 and U19 groups, resulting in a lower representation of these age groups. Yet, we do not know if more data, obtained from a larger number of players in these age groups, would have affected the results of this study. In addition, the competitive nature of the sport increases with age in youth teams, which can lead to more injuries as well as more serious injuries in higher age groups.

Training exposure was calculated at the team level and corrected by subtracting missed exposure as a result of injury. Individual training exposure data would have improved the accuracy of risk estimates. The club and the resources available did not allow this.

Furthermore, we calculated the age at PHV according the method described by Mirwald et al.^[@bibr15-2325967118811042]^ It should be acknowledged that this has lower accuracy than the Tanner-Whitehouse method, but a clear advantage is the lack of stochastic radiation effects occurring in case of repeated measures.^[@bibr21-2325967118811042]^

In addition, we do not know whether the first injury in the study was the first injury of the player in question, and the underlying causes of injuries (recorded according to the Orchard Sports Injury Classification System classification) were not registered. We could not separate the growth-related injuries in the overuse injury group. It is therefore possible that first-year players in the academy have a greater chance of injuries because they have to adapt to new training and competition regimens (regarding volume, intensity, or rhythm).

Generalizability {#section19-2325967118811042}
----------------

Generalizing these findings to other sports or soccer populations is questionable. Geographical and cultural differences may result in differences between types and volumes of training, surface and weather conditions, and other athletic participation in free time or at school. Comparisons with other sports seem impossible because injury patterns may differ widely. We are unaware of any other existing data on the relationship between biological/chronological age and sport injury, except for those described in this study.^[@bibr13-2325967118811042],[@bibr23-2325967118811042],[@bibr24-2325967118811042]^

Conclusion {#section20-2325967118811042}
==========

There was a higher injury risk (31%) in young academy soccer players during a period of 6 months after the age of PHV. This increased risk (49%) also existed in the chronologically classified U15 group. Based on the higher injury burden in the U15 (28%), U16 (48%), and U17 (21%) groups, we suggest that research on injury risk factors and preventive measures should primarily target these age groups. Additional PHV measurements seem to be of limited value from a screening perspective. Studies on different soccer academies with similar data registration are warranted to further establish the relation and interaction between the injury risk and injury burden in periods of growth and aging.
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